Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats

Brain Research

Volumn 1315, Issue , 2010, Pages 128-136

  Kranz, Alexander ^a   Wagner, Daniel Christoph ^a   Kamprad, Manja ^c   Scholz, Markus ^c   Schmidt, Uwe Richard ^a   Nitzsche, Franziska ^a   Aberman, Zami ^d   Emmrich, Frank ^a,b,c   Riegelsberger, Ute Maria ^a   Boltze, Johannes ^a  

^a FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^b Translational Centre for Regenerative Medicine   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d MATAM Advanced Technology Park # 20   (Israel)

Author keywords

Astrocytes; Cell Transplantation; Placenta; Rat; Stroke

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; CELL THERAPY; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; EXPERIMENTAL STUDY; FEMALE; FETUS; HUMAN; HUMAN TISSUE; HYPERTENSION; IN VIVO STUDY; MACROGLIA; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; NEUROLOGICAL SEVERITY SCORE SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PLACENTA; PRIORITY JOURNAL; RAT; SCORING SYSTEM; STROKE;

ANIMALS; ASTROCYTES; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEUROPSYCHOLOGICAL TESTS; PLACENTA; PREGNANCY; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; SEVERITY OF ILLNESS INDEX; STROKE; STROMAL CELLS; TIME FACTORS;

RATTUS;

EID: 75349097509     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.12.001     Document Type: Article

References (36)

1. Ajmo Jr. C.T., Vernon D.O., Collier L., Hall A.A., Garbuzova-Davis S., Willing A., and Pennypacker K.R. The spleen contributes to stroke-induced neurodegeneration. J. Neurosci. Res. 86 (2008) 2227-2234
2. Bliss T., Guzman R., Daadi M., and Steinberg G.K. Cell transplantation therapy for stroke. Stroke 38 (2007) 817-826
3. Chang C.J., Yen M.L., Chen Y.C., Chien C.C., Huang H.I., Bai C.H., and Yen B.L. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells 24 (2006) 2466-2477
4. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., Sanchez-Ramos J., and Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32 (2001) 2682-2688
5. Chen J., Li Y., Katakowski M., Chen X., Wang L., Lu D., Lu M., Gautam S.C., and Chopp M. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J. Neurosci. Res. 73 (2003) 778-786
6. Chopp M., and Li Y. Treatment of neural injury with marrow stromal cells. Lancet. Neurol. 1 (2002) 92-100
7. Dong Y., and Benveniste E.N. Immune function of astrocytes. Glia 36 (2001) 180-190
8. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., and Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24 (2004) 2143-2155
9. Gao Q., Li Y., and Chopp M. Bone marrow stromal cells increase astrocyte survival via upregulation of phosphoinositide 3-kinase/threonine protein kinase and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways and stimulate astrocyte trophic factor gene expression after anaerobic insult. Neuroscience 136 (2005) 123-134
10. Himeda T., Tounai H., Hayakawa N., and Araki T. Postischemic alterations of BDNF, NGF, HSP 70 and ubiquitin immunoreactivity in the gerbil hippocampus: pharmacological approach. Cell. Mol. Neurobiol. 27 (2007) 229-250
11. Hu J., Ferreira A., and Van Eldik L.J. S100beta induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69 (1997) 2294-2301
12. Hurn P.D., Subramanian S., Parker S.M., Afentoulis M.E., Kaler L.J., Vandenbark A.A., and Offner H. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J. Cereb. Blood Flow. Metab. 27 (2007) 1798-1805
13. In 't Anker P.S., Scherjon S.A., Kleijburg-van der K.C., de Groot-Swings G.M., Claas F.H., Fibbe W.E., and Kanhai H.H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22 (2004) 1338-1345
14. Jones B.J., Brooke G., Atkinson K., and McTaggart S.J. Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells. Placenta 28 (2007) 1174-1181
15. Kundrotiene J., Wagner A., and Liljequist S. Extradural compression of sensorimotor cortex: a useful model for studies on ischemic brain damage and neuroprotection. J. Neurotrauma 19 (2002) 69-84
16. Le Blank K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5 (2003) 485-489
17. Lee M.Y., Deller T., Kirsch M., Frotscher M., and Hofmann H.D. Differential regulation of ciliary neurotrophic factor (CNTF) and CNTF receptor alpha expression in astrocytes and neurons of the fascia dentata after entorhinal cortex lesion. J. Neurosci. 17 (1997) 1137-1146
18. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., Katakowski M., Zhang L.J., Lu M., Janakiraman N., and Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59 (2002) 514-523
19. Liberto C.M., Albrecht P.J., Herx L.M., Yong V.W., and Levison S.W. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89 (2004) 1092-1100
20. Marti H.H., and Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc. Natl. Acad. Sci. U. S. A 95 (1998) 15809-15814
21. Nishishita T., Ouchi K., Zhang X., Inoue M., Inazawa T., Yoshiura K., Kuwabara K., Nakaoka T., Watanabe N., Igura K., Takahashi T.A., and Yamashita N. A potential pro-angiogenic cell therapy with human placenta-derived mesenchymal cells. Biochem. Biophys. Res. Commun. 325 (2004) 24-31
22. Okawa H., Okuda O., Arai H., Sakuragawa N., and Sato K. Amniotic epithelial cells transform into neuron-like cells in the ischemic brain. Neuroreport 12 (2001) 4003-4007
23. Prather W.R., Toren A., and Meiron M. Placental-derived and expanded mesenchymal stromal cells (PLX-I) to enhance the engraftment of hematopoietic stem cells derived from umbilical cord blood. Expert. Opin. Biol. Ther. 8 (2008) 1241-1250
24. Prather W.R., Toren A., Meiron M., Ofir R., Tschope C., and Horwitz E.M. The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. Cytotherapy 11 4 (2009) 427-434
25. Roelen D.L., van der Mast B.J., in't Anker P.S., Kleijburg C., Eikmans M., van B.E., de Groot-Swings G.M., Fibbe W.E., Kanhai H.H., Scherjon S.A., and Claas F.H. Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells, Hum. Immunol 70 (2009) 16-23
26. Schabitz W.R., Berger C., Kollmar R., Seitz M., Tanay E., Kiessling M., Schwab S., and Sommer C. Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke 35 (2004) 992-997
27. Shen L.H., Li Y., Chen J., Zacharek A., Gao Q., Kapke A., Lu M., Raginski K., Vanguri P., Smith A., and Chopp M. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J. Cereb. Blood Flow. Metab. 27 (2007) 6-13
28. Silver J., and Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5 (2004) 146-156
29. Strachan R.D., Kane P.J., Cook S., Chambers I.R., Clayton C.B., and Mendelow A.D. Immunosuppression by whole-body irradiation and its effect on oedema in experimental cerebral ischaemia. Acta Neurol. Scand. 86 (1992) 256-259
30. Tamura A., Graham D.I., McCulloch J., and Teasdale G.M. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow. Metab. 1 (1981) 53-60
31. Toyama K., Honmou O., Harada K., Suzuki J., Houkin K., Hamada H., and Kocsis J.D. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp. Neurol. 216 (2009) 47-55
32. Trendelenburg G., and Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 50 (2005) 307-320
33. Wei O.Y., Huang Y.L., Da C.D., and Cheng J.S. Alteration of basic fibroblast growth factor expression in rat during cerebral ischemia. Acta Pharmacol. Sin. 21 (2000) 296-300
34. Yen B.L., Huang H.I., Chien C.C., Jui H.Y., Ko B.S., Yao M., Shun C.T., Yen M.L., Lee M.C., and Chen Y.C. Isolation of multipotent cells from human term placenta. Stem. Cells. 23 (2005) 3-9
35. Zhao M.Z., Nonoguchi N., Ikeda N., Watanabe T., Furutama D., Miyazawa D., Funakoshi H., Kajimoto Y., Nakamura T., Dezawa M., Shibata M.A., Otsuki Y., Coffin R.S., Liu W.D., Kuroiwa T., and Miyatake S. Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. J. Cereb. Blood Flow. Metab. 26 (2006) 1176-1188
36. Zhu H., Mitsuhashi N., Klein A., Barsky L.W., Weinberg K., Barr M.L., Demetriou A., and Wu G.D. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 24 (2006) 928-935